Association Between Health Plan Design and the Demand for Naloxone: Evidence From a Natural Experiment in New York

This publication has 30 references indexed in Scilit:

• Naloxone Knowledge, Carrying, Purchase, and Use
  JAMA Network Open, 2025
• Association Between Cost Sharing and Naloxone Prescription Dispensing
  JAMA, 2024
• Patients presenting to the ED with nonfatal drug overdose: Self-reported history of overdose and naloxone use
  The American Journal of Emergency Medicine, 2024
• Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Naloxone by Payer Type
  JAMA, 2024
• Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021
  JAMA Psychiatry, 2023
• The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths
  American Journal of Preventive Medicine, 2022
• Financial Burdens of Out-of-Pocket Prescription Drug Expenditures under High-Deductible Health Plans
  Journal of General Internal Medicine, 2020
• Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017
  JAMA, 2019
• Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
  JAMA Network Open, 2019
• Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
  JAMA Internal Medicine, 2019